Erinacine E
Erinacine E is a diterpenoid compound classified as a cyathane-type diterpene. It is one of the bioactive components isolated from the mycelium of the medicinal mushroom Hericium erinaceus, commonly known as lion's mane mushroom. Erinacine E is of significant interest in the field of neuropharmacology due to its potential neuroprotective and neuroregenerative properties.
Chemical Structure and Properties[edit]
Erinacine E is a member of the erinacine family, which includes several other related compounds such as erinacine A, B, C, and D. These compounds share a similar cyathane skeleton but differ in their functional groups and side chains. Erinacine E is characterized by its unique chemical structure that includes a tricyclic diterpene core.
Biological Activity[edit]
Erinacine E has been studied for its ability to stimulate the synthesis of nerve growth factor (NGF) in vitro. NGF is a neurotrophin essential for the growth, maintenance, and survival of certain neurons. The ability of erinacine E to enhance NGF synthesis suggests its potential use in treating neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Neuroprotective Effects[edit]
Research indicates that erinacine E may exert neuroprotective effects by reducing oxidative stress and inflammation in neuronal cells. These properties make it a promising candidate for further investigation in the context of neurodegenerative disorders.
Neuroregenerative Potential[edit]
In addition to its neuroprotective effects, erinacine E has been shown to promote neurogenesis, the process by which new neurons are formed in the brain. This is particularly important for recovery from neural injuries and for maintaining cognitive function in aging populations.
Sources and Extraction[edit]
Erinacine E is primarily extracted from the mycelium of Hericium erinaceus. The extraction process typically involves culturing the mycelium under controlled conditions, followed by solvent extraction and purification techniques such as high-performance liquid chromatography (HPLC).
Potential Applications[edit]
Given its neurotrophic and neuroprotective properties, erinacine E is being explored for its potential applications in dietary supplements and functional foods aimed at supporting brain health. However, more clinical research is needed to fully understand its efficacy and safety in humans.
Research and Development[edit]
Ongoing research is focused on elucidating the molecular mechanisms underlying the effects of erinacine E, as well as its pharmacokinetics and bioavailability. Animal studies and preliminary human trials are being conducted to assess its therapeutic potential and optimal dosing regimens.
Also see[edit]
This mushroom-related article is a stub. You can help WikiMD by expanding it.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian